Open AccessSynthetic analogs of vitamin D3 in therapy of psoriasis
Author(s) -
И. В. Петрова,
Петрова Инна Викторовна,
Rasul M. Radzhabov,
Раджабов Расул Мурадисович,
Abdul R. Abdulov,
Абдулов Абдул Рашидович,
Magomed G. Manatov,
Манатов Магомед Гаджимурадович,
Ruslan I. Glushakov,
Глушаков Руслан Иванович,
С. Н. Прошин,
Прошин Сергей Николаевич
Publication year - 2018
Publication title -
obzory po kliničeskoj farmakologii i lekarstvennoj terapii
Language(s) - English
Resource type - Journals
eISSN - 2542-1875
pISSN - 1683-4100
DOI - 10.17816/rcf16449-54
Subject(s) - calcipotriol , psoriasis , medicine , dermatology , vitamin , vitamin d and neurology , population , therapeutic effect , mechanism of action , pharmacology , biology , biochemistry , environmental health , in vitro
Psoriasis is one of the most common skin diseases and occurs in 1-2% of the population of developed countries. The problem of pathogenetic treatment of psoriasis remains relevant despite the annual appearance of new drugs. The anti-keratinizing effect is particularly important in the treatment of psoriasis. The effect is based on suppression of the proliferation of epidermal keratinocytes, normalization of the differentiation of the nonkeratinizing epithelium and the decrease in the adhesion of horny cells. The last decade is characterized by a deepening of ideas about the biological properties and mechanism of action of vitamin D3. However the vitamin D3 does itself not have therapeutic activity. In this connection the use of synthetic analogues of vitamin D3 which have therapeutic activity is particular of importance.
The aim. To evaluate the effectiveness of vitamin D3synthetic analogs for the treatment of psoriasis.
Methods. It was retrospective analysis of multicentric studies by a double-blind, randomized method of the effectiveness of vitamin D3 analogs for the treatment of psoriasis in Russia and foreign clinics. The PASI index in assessing the clinical manifestations of psoriasis.
Rеsults and discussion. The study of the clinical efficacy of oral forms of the vitamin indicates a positive therapeutic effect in 70-90% of patients but this requires an average of 2.8 months. Therefore for the treatment of psoriasis more widely used synthetic analogue of vitamin D3 – calcipotriol (MS-903), developed exclusively for topical application. Calcipotriol gives minimal side effects and has an intense antipsoriatic effect. The mechanism of action of calcipotriol is based on interaction with specific receptors on keratinocytes which causes inhibition of proliferation, accelerates the morphological differentiation of psoriatic cells, inhibits the activity of interleukin-1 and reduces interleukin-2 production, i.e. has an effect on the pathogenetic mechanisms of psoriasis.
Conclusion. Vitamin D3 analogues are effective antipsoriatic drugs that can be used both as monotherapy and in the complex treatment of patients with severe psoriasis.